Immunovant, Inc. IMVT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s current ratio?
- Immunovant, Inc. (IMVT) reported current ratio of 9.1× in Q1 2026.
- How has Immunovant, Inc.'s current ratio changed year-over-year?
- Immunovant, Inc.'s current ratio decreased by 18.6% year-over-year, from 11.2× to 9.1×.
- What is the long-term trend for Immunovant, Inc.'s current ratio?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s current ratio has grown at a -16.0% compound annual growth rate (CAGR), from 21.8× to 9.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.